Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anemia Therapy
Darbepoetin alfa saves costs and reduces number of office visits for treatment-related anemia
March 24th, 2006
Darbepoetin alfa is as effective as epoetin alfa, but is less expensive and reduces the number of patient office visits. Researchers in the United States conducted a study "to review and compare the data concerning the clinical activity of epoetin alfa versus darbepoetin alfa when administered to patients with cancer who are experiencing treatment-related anemia." "English-language publications from the MEDLINE database (1990-June 2005), published articles, and meeting abstracts were reviewed. Relevant data were extracted from published reports and abstracts on studies of humans with cancer who developed treatment-related anemia and were treated with...
Source: Drug Week (2006-03-24)
|
